These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8712033)

  • 1. Electrocardiographic changes in patients receiving neuroleptic medication.
    Warner JP; Barnes TR; Henry JA
    Acta Psychiatr Scand; 1996 Apr; 93(4):311-3. PubMed ID: 8712033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients.
    Reilly JG; Ayis SA; Ferrier IN; Jones SJ; Thomas SH
    Lancet; 2000 Mar; 355(9209):1048-52. PubMed ID: 10744090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control study.
    Correll CU; Harris J; Figen V; Kane JM; Manu P
    J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):365-8. PubMed ID: 21823910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval.
    Barbui C; Bighelli I; Carrà G; Castellazzi M; Lucii C; Martinotti G; Nosè M; Ostuzzi G;
    PLoS One; 2016; 11(2):e0148212. PubMed ID: 26840602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for QTc prolongation in schizophrenic patients taking antipsychotics.
    Lin CH; Chen MC; Wang SY; Lin CY
    J Formos Med Assoc; 2004 Jun; 103(6):437-41. PubMed ID: 15278188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QTc interval measurement and metabolic parameters in psychiatric patients taking typical or atypical antipsychotic drugs: a preliminary study.
    Mackin P; Young AH
    J Clin Psychiatry; 2005 Nov; 66(11):1386-91. PubMed ID: 16420075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-generation antipsychotics and QTc: any role for mediating variables?
    Carrà G; Crocamo C; Bartoli F; Lax A; Tremolada M; Lucii C; Martinotti G; Nosè M; Bighelli I; Ostuzzi G; Castellazzi M; Clerici M; Barbui C;
    Hum Psychopharmacol; 2016 Jul; 31(4):313-8. PubMed ID: 27245736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced long QT in adult psychiatric inpatients: the 5-year cross-sectional ECG Screening Outcome in Psychiatry study.
    Girardin FR; Gex-Fabry M; Berney P; Shah D; Gaspoz JM; Dayer P
    Am J Psychiatry; 2013 Dec; 170(12):1468-76. PubMed ID: 24306340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QTc-interval abnormalities in a forensic population.
    Girgis S; Huckstep B; Oakley J; Ferriter M; Nikolaou V
    Crim Behav Ment Health; 2007; 17(2):75-88. PubMed ID: 17295199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review.
    Porta-Sánchez A; Gilbert C; Spears D; Amir E; Chan J; Nanthakumar K; Thavendiranathan P
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29217664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The QTc interval and its dispersion in patients receiving two atypical antipsychotics.
    Correll CU; Frederickson AM; Figen V; Ginn-Scott EJ; Pantaleon Moya RA; Kane JM; Manu P
    Eur Arch Psychiatry Clin Neurosci; 2009 Feb; 259(1):23-7. PubMed ID: 18574608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic surveillance in a psychiatric institution: avoiding iatrogenic cardiovascular death.
    Rodríguez-Leal CM; López-Lunar E; Carrascosa-Bernáldez JM; Provencio-Arranz RM
    Int J Psychiatry Clin Pract; 2017 Mar; 21(1):64-66. PubMed ID: 27686282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged QTc intervals in medicated patients with schizophrenia.
    Chong SA; Mythily ; Lum A; Goh HY; Chan YH
    Hum Psychopharmacol; 2003 Dec; 18(8):647-9. PubMed ID: 14696025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.
    Haddad PM; Anderson IM
    Drugs; 2002; 62(11):1649-71. PubMed ID: 12109926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium.
    Vandael E; Vandenberk B; Vandenberghe J; Spriet I; Willems R; Foulon V
    Int J Clin Pharm; 2016 Apr; 38(2):310-20. PubMed ID: 26749342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QTc variability in schizophrenia patients treated with antipsychotics and healthy controls.
    Rettenbacher MA; Eder-Ischia U; Bader A; Edlinger M; Hofer A; Hummer M; Kemmler G; Weiss EM; Hochleitner M; Fleischhacker WW
    J Clin Psychopharmacol; 2005 Jun; 25(3):206-10. PubMed ID: 15876897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QTc interval in a sample of long-term schizophrenia inpatients.
    Ramos-Ríos R; Arrojo-Romero M; Paz-Silva E; Carballal-Calvo F; Bouzón-Barreiro JL; Seoane-Prado J; Codesido-Barcala R; Crespí-Armenteros A; Fernández-Pérez R; López-Moríñigo JD; Tortajada-Bonaselt I; Diaz FJ; de Leon J
    Schizophr Res; 2010 Jan; 116(1):35-43. PubMed ID: 19892525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Real-World Study of Risk Factors for QTc Prolongation in Schizophrenia Patients Receiving Atypical Antipsychotics.
    He L; Yu Y; Zhang L; He S; Yu W; Li L; Huang J; Li H
    J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):71-74. PubMed ID: 34928562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
    Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
    Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia.
    Ozeki Y; Fujii K; Kurimoto N; Yamada N; Okawa M; Aoki T; Takahashi J; Ishida N; Horie M; Kunugi H
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):401-5. PubMed ID: 20079791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.